Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
104.946,42
0,21%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sunshine Biopharma Inc (SBFM) Sunshine Biopharma Inc (SBFM) Notizie

SBFM

Sunshine Biopharma (SBFM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SBFM
DataOraFonteTitoloSimboloCompagnia
20/08/202422:05Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:SBFMSunshine Biopharma Inc
19/08/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
16/08/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMSunshine Biopharma Inc
14/08/202422:05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SBFMSunshine Biopharma Inc
11/07/202422:00Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:SBFMSunshine Biopharma Inc
05/03/202422:37Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
05/03/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
23/02/202422:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
14/02/202417:18Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SBFMSunshine Biopharma Inc
13/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SBFMSunshine Biopharma Inc
09/02/202423:17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SBFMSunshine Biopharma Inc
09/02/202414:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
01/02/202422:17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SBFMSunshine Biopharma Inc
08/01/202414:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SBFMSunshine Biopharma Inc
04/12/202314:30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMSunshine Biopharma Inc
19/10/202318:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SBFMSunshine Biopharma Inc
18/10/202319:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
25/08/202321:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
11/08/202314:30GlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMSunshine Biopharma Inc
06/06/202312:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBFMSunshine Biopharma Inc
05/06/202323:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SBFMSunshine Biopharma Inc
25/05/202322:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SBFMSunshine Biopharma Inc
17/05/202319:31Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SBFMSunshine Biopharma Inc
16/05/202315:58GlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
12/05/202314:00GlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
11/05/202323:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBFMSunshine Biopharma Inc
11/05/202315:00GlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMSunshine Biopharma Inc
10/05/202322:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SBFMSunshine Biopharma Inc
05/04/202314:00GlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMSunshine Biopharma Inc
04/04/202312:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SBFMSunshine Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SBFM

La tua Cronologia

BOV
A1LB34Q
Albemarle
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network